Pantoprazol Amarox (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Amarox, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Pantoprazol Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Amarox is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and erosion healing. - Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Peptic ulcer disease: aids in ulcer healing and reduces recurrence.

Pantoprazol Amarox may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe hypersensitivity: rash, angio‑edema, anaphylaxis. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, arrhythmia. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: renal impairment. - Liver enzyme elevation: hepatitis signs.

When prescribing Pantoprazol Amarox, consider the following precautions: - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function tests. - Long‑term therapy: assess need periodically to avoid bone density loss. - Concomitant use with clopidogrel: evaluate benefit‑risk balance. - Pregnancy and lactation: use only if clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and light.

Pantoprazol Amarox can interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential INR elevation. - Digoxin: altered serum levels. - Phenytoin: reduced plasma concentration. - Oral contraceptives: possible decreased efficacy.